Abstract
This presentation will give an overview of the current use of nanoparticles as drug carriers and will discuss their future use in drug targeting and drug delivery of active molecules. Today's progress in cell biology and biotechnology enables scientists to synthesize highly active molecules to target specific intra-cellular receptors. The clinical use of such molecules is often very limited because of their peptide or oligonucleotide nature. They are highly active in vitro in isolated cell systems, but a short half-life or limited cell uptake in vivo prevent their clinical use. To overcome the limitations in cellular uptake of highly active molecules, the use of nano-sized carriers is the focus of modern drug delivery strategies. The utilization of such particles as drug targeting vectors is an emerging field of pharmaceutical sciences.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.